Fifty one percent severely dehydrated with Systolic BP ranged 0.0-160.0mmHg, median 90.0mmHg. Diastolic BP ranged 0.0-110.0 mmHg, median 60.0mmHg. Total fluids given ranged 0.0-13.9 L, median 5.2 L. Only 1.4% had fluid output monitored. Lacking health insurance (POR= 2.52, CI0.48-13.25), being referred (POR= 0.05, CI0.01-0.21), male (POR= 0.82, CI0.32-2.16), single (POR= 0.80,) were associated with late hospital presentation COnClusIOns: Instituting routine cholera death audits in Ghana is crucial to reducing case fatality as late presentation, inadequacy of assessment, rehydration, monitoring and lack of Health Insurance were main prevalent factors among deaths in the outbreak. ObjeCtIves: Influenza infection can be recorded under number of respiratory diagnoses when patients visit a GP. In addition, the incidence of influenza and respiratory infections are known to be highest in younger and elderly age groups. Our objective was to describe the consultation rates for eight respiratory diagnoses across four influenza seasons as observed through GP consultations in England. MethOds: Data were obtained on 775,000 respiratory related GP consultations, across four influenza seasons (2010)(2011)(2012)(2013)(2014) from the Clinical Practitioners Research Datalink. Eligible patients were registered and had 12 months history with a practice at the start of the season. An influenza season was defined as 1 September through to 13 April of the following year. Practice-level consultation rates for each outcome were determined by age (seven groups were defined) and season. A Poisson mixed effect model was fitted to analyse age effect with inter-practice and inter-season as random effects. 18 to 65 age group was the reference population. Results: Across all outcomes, consultation rates for influenza or respiratory illness were highest amongst young children, with highest rates observed for the 0 to < 2 age group, followed by the 2 to < 4 age group. Focussing on individual diagnoses recorded during GP consultations, younger children were particularly at risk for upper respiratory tract infection and otitis media. Patients over 65 were found to be more at risk for pneumonia and lower respiratory tract infection. Inter-practice variation in diagnoses rates was dominating inter-season variations for most influenza-related diagnoses. Biggest seasonal impact was on consultations for influenza-like-illness, which were particularly high during the 2010-2011 season, likely due to the H1N1 epidemic. COnClusIOns: Our findings confirmed that children and the over 65 population are most at risk of influenza and respiratory illness, and that incidence can reliably be evaluated through analysis of GP consultation rates.
ObjeCtIves: Influenza infection can be recorded under number of respiratory diagnoses when patients visit a GP. In addition, the incidence of influenza and respiratory infections are known to be highest in younger and elderly age groups. Our objective was to describe the consultation rates for eight respiratory diagnoses across four influenza seasons as observed through GP consultations in England. MethOds: Data were obtained on 775,000 respiratory related GP consultations, across four influenza seasons (2010) (2011) (2012) (2013) (2014) from the Clinical Practitioners Research Datalink. Eligible patients were registered and had 12 months history with a practice at the start of the season. An influenza season was defined as 1 September through to 13 April of the following year. Practice-level consultation rates for each outcome were determined by age (seven groups were defined) and season. A Poisson mixed effect model was fitted to analyse age effect with inter-practice and inter-season as random effects. 18 to 65 age group was the reference population. Results: Across all outcomes, consultation rates for influenza or respiratory illness were highest amongst young children, with highest rates observed for the 0 to < 2 age group, followed by the 2 to < 4 age group. Focussing on individual diagnoses recorded during GP consultations, younger children were particularly at risk for upper respiratory tract infection and otitis media. Patients over 65 were found to be more at risk for pneumonia and lower respiratory tract infection. Inter-practice variation in diagnoses rates was dominating inter-season variations for most influenza-related diagnoses. Biggest seasonal impact was on consultations for influenza-like-illness, which were particularly high during the 2010-2011 season, likely due to the H1N1 epidemic. COnClusIOns: Our findings confirmed that children and the over 65 population are most at risk of influenza and respiratory illness, and that incidence can reliably be evaluated through analysis of GP consultation rates. ObjeCtIves: Hospital-treated pneumonias (HTP) are associated with substantial individual and societal burden in adults (≥ 50 years) and elderly. Moreover, adults e.g. with vascular, metabolic or respiratory diseases have a 3-6 times higher risk of HTP when compared with their healthy controls. Persons at risk are likely to benefit most from pneumococcal vaccinations. The 13-valent pneumococcal conjugate vaccine (PCV13) has showed to prevent community-acquired pneumonia and invasive pneumococcal disease in adults. The objective of this study was to estimate the expected 5-year health economic impact of targeted PCV13 compared with no vaccination in Finnish home care customers. MethOds: A budget impact model was developed to predict the impact of PCV13 vaccination in terms of costs and HTP events avoided at the national and municipal level. A dynamic-cohort Markov modelling approach and a time horizon of 5 years was used. The baseline number of home care customers and HTP events were gathered from Finnish national registries. The efficacy of PCV13 was estimated based on CAPITA trial. Only direct costs in 2014 value were considered in the analysis. Results: All 105,572 Finnish home care customers are considered to be at moderate or high risk for HTP because of underlying chronic medical conditions. Vaccination of these people with PCV13 could provide an undiscounted net budget savings of about € 49.2 million compared with the current no-vaccination situation over the next 5 years. Among the risk groups considered, the largest absolute undiscounted net savings (€ 22.3 million) could be obtained by vaccinating people with heart disease, due to its high prevalence in the target population. COnClusIOns: In Finland, the direct immunization of home care customers with PCV13, is estimated to lead to substantial cost savings in the following 5 years after vaccination. ObjeCtIves: Chronic HCV is a leading cause of hospitalization and death in populations coinfected with HIV in Italy. Sofosbuvir (SOF) is a pan-genotypic drug, which can be used alone or combined with other agents (e.g.Simeprevir,Daclatasvir, Ledipasvir) as oral treatment for HCV, with different price levels. We performed
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Degli Esposti L 1 , Sangiorgi D 1 , Buda S 1 , Crovato E 1 , Nappi C 2 , Lefevre C 3 1 CliCon S.r.l., Ravenna, Italy, 2 Bristol Myers Squibb S.r.l., Roma, Italy, France ObjeCtIves: To estimate prevalence of HCV, using data from routine practice in Italy MethOds: An observational retrospective cohort based on administrative databases (containing data from pharmacy registries, hospital discharges, outpatient specialist services and laboratory tests) from a sample of six Italian LHUs was performed. The date of the first record related to HCV (i.e., positive HCV testing or medications for HCV) during the study period (July 1st, 2009 -June 31st, 2014) was considered as a proxy of diagnosis, and used as the index date. Patients with data available for at least 6 months prior to index date were followed up from the index date until the first of the end of the study period, date of death, or exiting the database Results: Overall, 228,157 health-assisted individuals living in the first analysed LHU (Central Italy) were considered as the starting population in the study; amongst them, 0.4% patients with HCV were enrolled, 56% male, age 58±16 years. The most prevalent genotypes were 1 (51±2%), 2 (24±2%), 3 (19±2%) and 4 (5±1%); other genotypes had a rate lower than 5%. In terms of co-infections, 6% patients were affected by HIV, 3% by HBV, 2% HCV+HBV+HIV, 26% had cirrhosis and 4% HCC. The majority of patients (76%) did not receive an antiviral treatment; compared to treated patients, they were more frequently aged > 65 years (44% compared to 14% in treated patients), females (46%, vs 40%), under ongoing substance/alcohol abuse (7% vs 4%). Moreover, 30% of untreated patients had cirrhosis and 5% HCC. Results from other LHUs will be available at ISPOR-EU COnClusIOns: This observational study showed that 70% of enrolled HCV patients has genotype 1 and 3, and only a small proportion of patients with HCV received antiviral therapy. Future analyses should investigate relationships between patients' characteristics, therapeutic choices and outcomes ObjeCtIves: Rotavirus gastroenteritis (RVGE) is the leading cause of severe diarrhea in children under 5 years of age. Two rotavirus vaccines are licensed to prevent these infections. More than hundred economic evaluations have been published on rotavirus vaccination since 2006 and their results largely vary. An update of a literature view was conducted aiming to assess whether differences in the epidemiological data used in European evaluations could explain the differences in the results obtained. MethOds: A literature review was conducted to retrieve articles reporting the cost-effectiveness of rotavirus vaccination in Europe based on criteria used in a previously published review (limited to 2001-2011 studies, this update extended the search to May 2015), focusing on epidemiological data. The following annual incidence RVGE-related data were extracted from the retrieved articles and grouped by countries: community-acquired hospitalisation (CAH), emergency department (ED) visits, outpatient visits (including general practitioner or paediatrician) and RVGE events (including no medical visits). Variations within countries were also calculated as the ratio between the maximum and minimum value. Results: 32 publications (24 manuscripts and 8 conference abstracts) from 13 European countries were retrieved. The European average (minimum and maximum reported value) annual rates were CAH 0.57% (0.09% Portugal; 1.43% Albania), ED visits 1.13% (0.22% Portugal; 2.40% France), outpatient visits 3.11% (0.56% Netherlands; 7.17% Romania) and RVGE events 9.05% (5.63% Germany; 20.01% Spain). For the countries with multiple publications, rates of CAH and outpatient visits showed large variation (CAH: France 2.82; outpatient: Ireland 5.78). RVGE rates were generally consistent except for United Kingdom (1.93) and Germany (2.50). For ED visit rates the largest variability was observed in France (3.16). COnClusIOns: The RGVE disease burden used as input in economic evaluation varies among the studies in the same country and across Europe. This may explain the difference in the cost-effective results reported. ObjeCtIves: Ghana has documented recurrent Cholera outbreaks (Davies-Teye, 2014) ; the worst ever in 2014 had high case, death incidence and yet does not routinely audit these deaths. Auditing the deaths would improve healthcare quality delivered to clients This study aimed at developing standardized Cholera Death audit tool, describe the deaths and identify prevalent factors that contributed to deaths. MethOds: Standardized cholera death audit tool was developed. Census of cholera deaths from June -December 2014 in Greater Accra Region made. Medical records, surveillance data of deaths from treatment centers reviewed with the developed audit tool. Data abstracted included socio-demographic, clinical, patient monitoring. Data managed in Epi info7. Descriptive, bivariate analysis made and Prevalent Odds Ratio (95% Confidence Interval) determined to identify prevalent factors associated with deaths. Results: The region documented 20,199 (Attack rate 432 per 100,000 populations) cholera cases with 121 deaths (CFR 0.60%). La NkwantanangMadina and Ladade Kotopon were most affected with Attack rates above 600 per 100,000 populations. Ada East, Ashaiman and LEKMA had case fatalities above 0.9%. Ages ranged 1-82 years, mean 41.0 ±17, median 39.0, mode 24.0 years. Males constituted 65.7% and 90.9% did not have health insurance. Duration of home stay ranged 0-5days. Nineteen percent were dead on arrival and 20.2% within 4hours of arrival.
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